← 返回

用 10 色流式细胞术以 90 种免疫细胞亚群监测人全血免疫状态的临床应用

英文原题:Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.

查看英文原题

Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.

PubMed 2021/04/18(内容时间) Int J Lab Hematol Q3 · IF 2.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们为通过多色流式细胞术检测来临床监测免疫状态并指导免疫治疗提供了可行性证据。

中文摘要

流式细胞术是进行免疫监测的理想技术,因为它能用少量样本在短时间内检测免疫细胞。全血是监测免疫状态的理想样本,几乎包含所有免疫细胞,且相较骨髓或淋巴结更易获取、侵入性更低。

研究者开发并验证了一套 10 色检测方案,仅需 4 个试管、29 种抗体,即可在 2 mL 全血样本中监测 90 个免疫细胞亚群。检测的主要群体包括 T 细胞亚群(CD3⁺总 T、辅助性 T、细胞毒性 T、Treg、CD8^hi、CD8^low、TCR 亚群、初始和记忆 T 细胞)、T 细胞活化标志物(CD25、CD69、HLA-DR)及免疫检查点 PD-1、B 细胞亚群(B1、转换记忆、非转换、初始 B 细胞及 CD27⁻IgD⁻ B 细胞)、中性粒细胞、嗜碱性粒细胞、4 类单核细胞亚群、树突状细胞(pDC 和 mDC)以及 4 类 NK 细胞亚群。研究者已将该抗体组合用于监测 303 例不同疾病患者的免疫状态(比例及绝对数),涵盖白血病(AML、CML、MM 和 ALL)、淋巴瘤(B 细胞及 NK/T 细胞)、结肠癌、肺癌、前列腺癌、乳腺癌、免疫缺陷和自身免疫病。

研究证明多色流式细胞术可用于临床免疫状态监测并指导免疫治疗。

展开英文摘要原文

Flow cytometry is the best technology to perform immune monitoring, because it can detect immune cells using small amount of sample in a short time. The whole blood is the ideal sample for immune status monitoring, since it includes almost all the immune cells and it's relatively easy to obtain and less invasive than bone marrow or lymph node.

Here we developed and validated a 10-color panel with only four tubes containing 29 antibodies to monitor 90 immune cell subsets in 2 ml whole blood samples. The major immune cell populations detected by our panel included T cell subsets (CD3 + total T, Th, Tc, Treg, CD8 hi , CD8 low , TCR, TCR, na ve, and memory T), T cell activation markers (CD25, CD69, and HLA-DR) and one immune checkpoint PD1, B cell subsets (B1, switched memory, non-switched, na ve B, and CD27 - IgD - B cells), neutrophils, basophils, four monocytic cell subsets, dendritic cells (pDCs and mDCs), and four NK cell subsets. These panels of antibodies had been applied to monitor immune status (percentage and absolute number) in total 303 cases with various diseases, such as leukemia (AML, CML, MM, and ALL), lymphoma (B cells and NK/T cells), cancers (colon, lung, prostate, and breast), immune deficiencies, and autoimmune diseases.

We provided proof of feasibility for clinical monitoring immune status and guiding immunotherapy by multicolor flow cytometry testing.

论文信息

作者
Wang W、Li H、Zhang L、Jiang W、Shen L、Fan G
第一作者单位
Department of Clinical laboratory, Xinhua hospital, Shanghai Jiaotong University of Medicine School, Shanghai, China.China
通讯作者单位
Department of Pathology, Oregon Health and Science University, Portland, OR, USA.United States
期刊
International journal of laboratory hematology2021 Oct
原文标识
PubMed 33870648 · DOI 10.1111/ijlh.13541